Magnetic resonance imaging in neuromyelitis optica
- 14 May 2014
- journal article
- review article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 20 (9), 1153-1164
- https://doi.org/10.1177/1352458514531087
Abstract
Neuromyelitis optica (NMO), or Devic’s disease, is a rare demyelinating disorder of the central nervous system that has a predilection for the optic nerve and spinal cord. Magnetic resonance imaging (MRI) is required to diagnose NMO. Longitudinally extensive transverse myelitis is NMO’s imaging hallmark and the presence of a brain MRI that is not diagnostic of multiple sclerosis (MS) also remains part of the diagnostic criteria. It is increasingly recognised that MS and NMO brain imaging can, however, have similar appearances but differences do exist: hypothalamic, periaqueductal grey and area postrema lesions implicate NMO whilst cortical, U-fibre or Dawson’s finger lesions are suggestive of MS. The timing of image acquisition, age, ethnicity and aquaporin-4 antibody status are all likely to alter the findings at MRI. This review therefore aims to overview and update the reader on NMO imaging, to provide clinically relevant guidance for diagnosing NMO and differentiating it from MS in order to guide management, and to highlight recent research insights.This publication has 58 references indexed in Scilit:
- Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 AntibodiesJAMA Neurology, 2013
- “Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosisMultiple Sclerosis Journal, 2013
- Natalizumab and the development of extensive brain lesions in neuromyelitis opticaZeitschrift für Neurologie, 2013
- Long‐term MRI findings in neuromyelitis optica: seropositive versus seronegative patientsEuropean Journal of Neurology, 2012
- IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrumNeurology, 2010
- Interferon Beta Treatment in Neuromyelitis OpticaArchives of Neurology, 2010
- The spectrum of neuromyelitis opticaThe Lancet Neurology, 2007
- Revised diagnostic criteria for neuromyelitis opticaNeurology, 2006
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisThe Lancet, 2004
- MRI in the diagnosis of MSNeurology, 1988